• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清学检测在多菌型麻风患者中的应用价值:抗体反应的临床及细菌学关联

Operational value of serological measurements in multibacillary leprosy patients: clinical and bacteriological correlates of antibody responses.

作者信息

Roche P W, Britton W J, Failbus S S, Williams D, Pradhan H M, Theuvenet W J

机构信息

Mycobacterial Research Laboratory, Anandaban Leprosy Hospital, Kathmandu, Nepal.

出版信息

Int J Lepr Other Mycobact Dis. 1990 Sep;58(3):480-90.

PMID:2205683
Abstract

The antibody responses of 100 previously untreated multibacillary (MB) leprosy patients to one protein and two carbohydrate antigens were examined: 94% of the patients had Mycobacterium leprae-specific antibodies; 89% directed to the species-specific epitope on phenolic glycolipid (PGL-I), 89% against the specific epitope on the 35-kDa protein, and 94% against one or both of the two. By contrast, 67% of the patients had anti-lipoarabinomannan (LAM) antibodies. There were trends for the seropositivity rate and the antibody level to rise with the increasing extent of the disease and as patients moved to the polar lepromatous end of the spectrum. The bacillary load, as measured by the bacterial index, was moderately correlated with the IgM anti-PGL-I and the anti-35-kDa antibody levels and, to a lesser extent, with the IgG antibodies directed at the common mycobacterial carbohydrate LAM. The sensitivity of the IgM anti-PGL-I antibodies for detecting smear-positive MB disease was 91%; that for the anti-35-kDa antibodies was 92%.

摘要

对100例未经治疗的多菌型(MB)麻风患者针对一种蛋白质抗原和两种碳水化合物抗原的抗体反应进行了检测:94%的患者有麻风分枝杆菌特异性抗体;89%针对酚糖脂(PGL-I)上的种特异性表位,89%针对35 kDa蛋白上的特异性表位,94%针对两者之一或两者。相比之下,67%的患者有抗脂阿拉伯甘露聚糖(LAM)抗体。血清阳性率和抗体水平有随着疾病程度增加以及患者向光谱的极型瘤型端转变而上升的趋势。通过细菌指数测量的菌负荷与IgM抗PGL-I和抗35 kDa抗体水平呈中度相关,在较小程度上与针对常见分枝杆菌碳水化合物LAM的IgG抗体相关。IgM抗PGL-I抗体检测涂片阳性MB病的敏感性为91%;抗35 kDa抗体的敏感性为92%。

相似文献

1
Operational value of serological measurements in multibacillary leprosy patients: clinical and bacteriological correlates of antibody responses.血清学检测在多菌型麻风患者中的应用价值:抗体反应的临床及细菌学关联
Int J Lepr Other Mycobact Dis. 1990 Sep;58(3):480-90.
2
Serological monitoring of the response to chemotherapy in leprosy patients.麻风病患者化疗反应的血清学监测。
Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):35-43.
3
Heterogeneity of serological responses in paucibacillary leprosy--differential responses to protein and carbohydrate antigens and correlation with clinical parameters.
Int J Lepr Other Mycobact Dis. 1990 Jun;58(2):319-27.
4
Antibody responses to the 18-kDa protein of Mycobacterium leprae in leprosy and tuberculosis patients.麻风病和结核病患者对麻风分枝杆菌18-kDa蛋白的抗体反应。
Int J Lepr Other Mycobact Dis. 1992 Jun;60(2):201-7.
5
Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.麻风流行地区麻风患者及健康接触者对重组65 kDa、70 kDa和18 kDa分枝杆菌抗原的抗体反应。
Int J Lepr Other Mycobact Dis. 1994 Jun;62(2):245-55.
6
Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions.对麻风病患者组织病理学谱中皮肤病变内分枝杆菌抗原原位表达的免疫组织学分析。分枝杆菌脂阿拉伯甘露聚糖(LAM)和麻风分枝杆菌酚糖脂-I(PGL-I)与麻风反应的关联。
Am J Pathol. 1999 Jun;154(6):1793-804. doi: 10.1016/S0002-9440(10)65435-1.
7
Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions.在多药治疗及反应期间监测麻风患者时,检测血清抗酚糖脂-I抗体、新蝶呤和C反应蛋白水平的效用。
Trop Med Int Health. 2007 Dec;12(12):1450-8. doi: 10.1111/j.1365-3156.2007.01951.x.
8
Detection of M. leprae-specific antigens with dot-ELISA in urine and nasal samples from leprosy patients.采用斑点酶联免疫吸附测定法检测麻风患者尿液和鼻拭子样本中的麻风杆菌特异性抗原。
Int J Lepr Other Mycobact Dis. 1991 Sep;59(3):398-404.
9
Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.对麻风病患者进行血清中针对酚糖脂-I(酚糖脂-I的合成类似物)和分枝杆菌脂阿拉伯甘露聚糖的抗体水平的连续监测。
Int J Lepr Other Mycobact Dis. 1990 Sep;58(3):503-11.
10
The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.多菌型麻风患者血清麻风分枝杆菌特异性抗原对化疗的反应。
Am J Trop Med Hyg. 1991 Jun;44(6):702-8. doi: 10.4269/ajtmh.1991.44.702.

引用本文的文献

1
Recent Laboratory Advances in Diagnostics and Monitoring Response to Treatment in Leprosy.麻风病诊断及治疗反应监测的近期实验室进展
Indian Dermatol Online J. 2019 Mar-Apr;10(2):106-114. doi: 10.4103/idoj.IDOJ_260_18.
2
Spatial epidemiology and serologic cohorts increase the early detection of leprosy.空间流行病学和血清学队列研究有助于麻风病的早期发现。
BMC Infect Dis. 2015 Nov 16;15:527. doi: 10.1186/s12879-015-1254-8.
3
Nasal mucosa study of leprosy contacts with positive serology for the phenolic glycolipid 1 antigen.麻风病接触者的鼻黏膜研究与酚糖脂 1 抗原的阳性血清学结果相关。
Braz J Otorhinolaryngol. 2010 Sep-Oct;76(5):579-87. doi: 10.1590/S1808-86942010000500008.
4
Rational design and evaluation of a multiepitope chimeric fusion protein with the potential for leprosy diagnosis.具有麻风病诊断潜力的多表位嵌合融合蛋白的合理设计与评估
Clin Vaccine Immunol. 2010 Feb;17(2):298-303. doi: 10.1128/CVI.00400-09. Epub 2009 Dec 16.
5
Selection of antigens and development of prototype tests for point-of-care leprosy diagnosis.用于即时检测麻风病诊断的抗原选择及原型检测方法的开发。
Clin Vaccine Immunol. 2008 Oct;15(10):1590-7. doi: 10.1128/CVI.00168-08. Epub 2008 Aug 20.
6
Use of protein antigens for early serological diagnosis of leprosy.蛋白质抗原在麻风病早期血清学诊断中的应用。
Clin Vaccine Immunol. 2007 Nov;14(11):1400-8. doi: 10.1128/CVI.00299-07. Epub 2007 Sep 26.
7
Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy.用于麻风病患者分类及识别有患麻风病高风险接触者的简单快速侧向流动检测。
J Clin Microbiol. 2003 May;41(5):1991-5. doi: 10.1128/JCM.41.5.1991-1995.2003.
8
Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy.在多药治疗开始前后检测麻风病患者血清中麻风分枝杆菌的酚糖脂I。
Clin Diagn Lab Immunol. 2001 Jan;8(1):138-42. doi: 10.1128/CDLI.8.1.138-142.2001.
9
Specific serological diagnosis of leprosy with a recombinant Mycobacterium leprae protein purified from a rapidly growing mycobacterial host.利用从快速生长的分枝杆菌宿主中纯化的重组麻风分枝杆菌蛋白进行麻风病的特异性血清学诊断。
J Clin Microbiol. 1998 Aug;36(8):2363-5. doi: 10.1128/JCM.36.8.2363-2365.1998.
10
A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae.一种35千道尔顿的蛋白质是人类针对麻风分枝杆菌免疫反应的主要靶点。
Infect Immun. 1996 Dec;64(12):5171-7. doi: 10.1128/iai.64.12.5171-5177.1996.